Starboard’s Bristol-Myers pitch needs an activist

📆 3/19/2019 8:09 PM
📰 Breakingviews

⏱ Reading Time:
8 sec. here
2 min. at publisher
📊 Quality Score:
News: 6%
Publisher: 51%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

Starboard Value’s Bristol-Myers pitch needs an activist. rob_cyran

Starboard Value filed a 197-page presentation on March 19 outlining its objections to Bristol-Myers Squibb’s $74 billion agreed deal to buy Celgene. The activist investor says the acquisition could destroy shareholder value because of the risk of patents expiring on Celgene’s marketed drugs, and overly optimistic assumptions about as-yet unapproved medicines.

It says Bristol-Myers could cut costs to become more efficient, and should continue with its past strategy of acquiring smaller firms.

Write Comment

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

The first-time founder’s ultimate guide to pitching a VCEntrepreneurship can feel like an uphill battle. Our guide for first-time company founders pitching venture capitalists will make it a little easier.
Source: BusinessInsider - 🏆 729. / 51 Read more »

Goldman Sachs job cuts — How to pitch VCs — Walmart's trucking ambitionsMy name's Matt Turner, and I'm the Executive Editor at Business Insider. Starting today, I'm going to be sending out a weekly email highlighting some of the best reporting from our BI Prime coverage.
Source: BusinessInsider - 🏆 729. / 51 Read more »